Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Alkermes Plc (ALKS)

Alkermes Plc (ALKS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,768,334
  • Shares Outstanding, K 164,312
  • Annual Sales, $ 1,174 M
  • Annual Income, $ -48,170 K
  • 60-Month Beta 0.57
  • Price/Sales 4.18
  • Price/Cash Flow 38.68
  • Price/Book 4.49
Trade ALKS with:

Options Overview Details

View History
  • Implied Volatility 39.03% ( -1.93%)
  • Historical Volatility 36.18%
  • IV Percentile 10%
  • IV Rank 20.15%
  • IV High 109.25% on 11/17/22
  • IV Low 21.31% on 03/11/22
  • Put/Call Vol Ratio 0.00
  • Today's Volume 753
  • Volume Avg (30-Day) 403
  • Put/Call OI Ratio 0.27
  • Today's Open Interest 12,022
  • Open Int (30-Day) 56,848

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate -0.09
  • Number of Estimates 6
  • High Estimate 0.00
  • Low Estimate -0.16
  • Prior Year 0.13
  • Growth Rate Est. (year over year) -169.23%

Price Performance

See More
Period Period Low Period High Performance
1-Month
24.91 +16.50%
on 12/28/22
29.05 -0.10%
on 01/27/23
+3.83 (+15.20%)
since 12/27/22
3-Month
22.09 +31.37%
on 11/16/22
29.05 -0.10%
on 01/27/23
+6.28 (+27.62%)
since 10/27/22
52-Week
21.75 +33.43%
on 10/11/22
32.79 -11.50%
on 04/28/22
+4.46 (+18.16%)
since 01/27/22

Most Recent Stories

More News
Alkermes to Present at the 41st Annual J.P. Morgan Healthcare Conference

/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that its Chief Executive Officer, Richard Pops, will provide a corporate overview and update at the...

ALKS : 29.02 (+1.82%)
Alkermes to Participate in the BofA Securities 2022 Biotech SMID Cap Conference

/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that management will participate in a fireside chat as part of the BofA Securities 2022 Biotech...

ALKS : 29.02 (+1.82%)
How Alkermes (ALKS) Stock Stands Out in a Strong Industry

Alkermes (ALKS) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.

ALKS : 29.02 (+1.82%)
Alkermes to Participate in the 5th Annual Evercore ISI HealthCONx Conference

/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that management will participate in a fireside chat at the 5th Annual Evercore ISI HealthCONx...

ALKS : 29.02 (+1.82%)
Alkermes to Participate in the Stifel Healthcare Conference

/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that management will participate in a fireside chat at the Stifel 2022 Healthcare Conference on...

ALKS : 29.02 (+1.82%)
Alkermes (ALKS) Q3 Earnings Meet Estimates, Revenues Miss

Alkermes' (ALKS) earnings meet estimates in the third quarter of 2022 while revenues miss the same. The company tightens total revenue guidance for 2022.

ALKS : 29.02 (+1.82%)
AVIR : 4.60 (+0.66%)
RCUS : 23.13 (+0.17%)
AKRO : 49.25 (+3.36%)
Alkermes (ALKS) Q3 Earnings Match Estimates

Alkermes (ALKS) delivered earnings and revenue surprises of 0% and 8.02%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

ALKS : 29.02 (+1.82%)
MRNA : 189.35 (-2.01%)
Alkermes: Q3 Earnings Snapshot

Alkermes: Q3 Earnings Snapshot

ALKS : 29.02 (+1.82%)
Alkermes plc Reports Third Quarter 2022 Financial Results

/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today reported financial results for the third quarter of 2022 and updated certain financial expectations for...

ALKS : 29.02 (+1.82%)
Acorda Therapeutics Reports Third Quarter 2022 Financial Results

Acorda Therapeutics, Inc. (Nasdaq: ACOR) today provided a business update and reported its financial results for the third quarter ended September 30, 2022.

ACOR : 0.9400 (-1.20%)
ALKS : 29.02 (+1.82%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Strongest short term outlook on maintaining the current direction.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Alkermes plc, formed by the merger of Waltham, MA-based Alkermes, Inc. and Elan Drug Technologies (EDT), is a fully integrated global biopharmaceutical company that utilizes proprietary technologies to research, develop and commercialize, both with partners and on its own pharmaceutical products in major...

See More

Key Turning Points

3rd Resistance Point 29.76
2nd Resistance Point 29.41
1st Resistance Point 29.21
Last Price 29.02
1st Support Level 28.66
2nd Support Level 28.31
3rd Support Level 28.11

See More

52-Week High 32.79
Last Price 29.02
Fibonacci 61.8% 28.57
Fibonacci 50% 27.27
Fibonacci 38.2% 25.97
52-Week Low 21.75

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar